These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products. Chen JP; Williams TK; Legendre AM Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573 [TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis]. Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330 [TBL] [Abstract][Full Text] [Related]
7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
9. Rheological and clotting changes in the immediate post-myocardial infarction period. Patrassi GM; Brunetti A; de Zio A; Gribaldo A; Cafiero F; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):140-9. PubMed ID: 6164609 [TBL] [Abstract][Full Text] [Related]
10. [Improved standard fibrin plate method and development of methods for rapid analysis of fibrinogen-fibrin degradation products]. Honi S; Inaoka Y; Ishibashi K; Kawagoe H Rinsho Byori; 1971 Aug; 19():Suppl:258. PubMed ID: 5290296 [No Abstract] [Full Text] [Related]
11. Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong. Chan JC; Kwok MM; Cockram CS; Prematilleke MN; Tomlinson B; Critchley JA Singapore Med J; 1993 Apr; 34(2):145-7. PubMed ID: 8266156 [TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic activity in Nigerian diabetics with renal insufficiency. Unuigbe EI; Famodu AA; Umunna CE Clin Hemorheol Microcirc; 2005; 32(1):13-7. PubMed ID: 15665422 [TBL] [Abstract][Full Text] [Related]
13. [Contribution to the research of fibrinolytic activity in hemorrhagic anemia]. Pstruzinová H; Richter V; Stamidis L; Luza E Z Gesamte Inn Med; 1966 Mar; 21(6):183-5. PubMed ID: 5988084 [No Abstract] [Full Text] [Related]
14. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. Marder VJ; Shulman NR; Carroll WR Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117 [No Abstract] [Full Text] [Related]
15. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta]. Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124 [TBL] [Abstract][Full Text] [Related]
16. Fibrinogen degradation products in plasma following induced hyperfibrinolysis. Chek JB; Panchenko NI East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907 [TBL] [Abstract][Full Text] [Related]
17. [Relationship between the state of blood-aqueous barrier and the fibrinolytic activity as well as plasma fibrinogen level]. Rudobielski R Klin Oczna; 1974 Feb; 44(2):123-7. PubMed ID: 4453092 [No Abstract] [Full Text] [Related]
18. [Studies on the fibrinolysis in chronic recurring urticaria with low fibrinogen level]. Braun H; Nitzschner H; Peschel H Z Haut Geschlechtskr; 1970 Nov; 45(22):761-4. PubMed ID: 5477135 [No Abstract] [Full Text] [Related]
19. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [TBL] [Abstract][Full Text] [Related]
20. [Micromethods of determining the concentration of fibrinogen, fibrinolytic activity, heparin and antifibrinolysin in blood]. Andreenko GV Lab Delo; 1969; 8():477-9. PubMed ID: 4193037 [No Abstract] [Full Text] [Related] [Next] [New Search]